Back to UBS Group AG UBS Group AG

OBIOOBIO
13 quarters

Position history for UBS Group AGUBS Group AG's holdings in ORCHESTRA BIOMED HLDGS INC

UBS Group AG holds 325,773 shares of OBIO (ORCHESTRA BIOMED HLDGS INC), worth $1.4M as of 2026-Q2. The position was increased (+547.5% shares). OBIO represents 0.0% of UBS Group AG's portfolio.

Current Value

$1.4M

Current Shares

325,773

Total Value Change

+$1.4M

Total Shares Change

+318,358

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
325,773
+547.5%
$1.4M0.0%$4.32
41
2026-Q1
Increased
50,310
+341.7%
$213,8180.0%$4.36
25
2025-Q4
Increased
11,389
+198.5%
$47,2650.0%$4.14
22
2025-Q3
Decreased
3,815
-85.4%
$9,4610.0%$2.46
0
2025-Q2
Increased
26,139
+51.4%
$70,0530.0%$2.78
20
2025-Q1
Decreased
17,270
-28.2%
$73,9160.0%$4.40
0
2024-Q4
Increased
24,065
+109.6%
$96,2600.0%$4.25
24
2024-Q3
Increased
11,482
+60.5%
$59,0180.0%$5.02
20
2024-Q2
Decreased
7,154
-51.4%
$58,3050.0%$8.15
0
2024-Q1
Increased
14,726
+9.6%
$77,6060.0%$5.27
16
2023-Q4
Increased
13,432
+79.2%
$122,6340.0%$9.13
23
2023-Q3
Increased
7,494
+1.1%
$65,3470.0%$8.72
14
2023-Q2
New
7,415
-
$51,9050.0%$7.57
32

Other major holders of OBIO: RTW INVESTMENTS, LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used